| 1 |
29799301 | Using flow cytometry to monitor glycoprotein IIb-IIIa activation. | 2018 Nov |
1 |
| 2 |
26652157 | Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond. | 2016 |
1 |
| 3 |
22490676 | Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin. | 2012 Jun 28 |
1 |
| 4 |
18809237 | FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2. | 2008 Dec |
1 |
| 5 |
9054743 | Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade. | 1997 Feb 18 |
1 |
| 6 |
7641602 | Novel antithrombotic drugs in development. | 1995 Jun |
1 |
| 7 |
8152339 | Role of platelet GpIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitors type-1 (PAI-1) release. | 1994 |
1 |
| 8 |
8373415 | Ligand interactions with the RGD recognition site alter binding of GPIIb-IIIa reactive monoclonal antibody to human platelets. | 1993 Sep 15 |
1 |
| 9 |
1783488 | Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation. | 1991 Aug |
1 |
| 10 |
2365698 | Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. | 1990 Jul 15 |
1 |